J Clin Neurol.
2020 Jul;16(3):383-389. 10.3988/jcn.2020.16.3.383.
Refining General Principles of Antiepileptic Drug Treatments for Epilepsy
- Kim KT
1 - Kim DW2
- Yang KI3
- Lee ST4
- Byun JI5
- Seo JG6
- No YJ7
- Kang KW8
- Kim D9
- Cho YW1
- on behalf of the Drug Committee of Korean Epilepsy Society
- Affiliations
-
- 1Department of Neurology, Keimyung University School of Medicine, Daegu, Korea.
- 2Department of Neurology, Konkuk University School of Medicine, Seoul, Korea.
- 3Department of Neurology, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Korea.
- 4Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- 5Department of Neurology, Kyunghee University Hospital at Gangdong, Seoul, Korea.
- 6Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea.
- 7Department of Neurology, Samsung Noble County, Yongin, Korea.
- 8Department of Neurology, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Korea.
- 9Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.
- KMID: 2506601
- DOI: http://doi.org/10.3988/jcn.2020.16.3.383
Abstract
- Antiepileptic drugs (AEDs) are the primary treatment strategy for epilepsy. As the use of AEDs has become more widespread and diverse over the past century, it has become necessary to refine the associated prescription strategies. This prompted the Drug Committee of the Korean Epilepsy Society to perform a systemic review of both international and domestic guidelines as well as literature related to medical treatment of epilepsy, and prepared a series of reviews to provide practical guidelines for clinicians to follow. This article is the first in a series on AED treatments for epilepsy in South Korea.
